Does BROLUCIZUMAB Cause Vitreous floaters? 74 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 74 reports of Vitreous floaters have been filed in association with BROLUCIZUMAB (BEOVU). This represents 10.9% of all adverse event reports for BROLUCIZUMAB.
74
Reports of Vitreous floaters with BROLUCIZUMAB
10.9%
of all BROLUCIZUMAB reports
0
Deaths
2
Hospitalizations
How Dangerous Is Vitreous floaters From BROLUCIZUMAB?
Of the 74 reports, 2 (2.7%) required hospitalization.
Is Vitreous floaters Listed in the Official Label?
Yes, Vitreous floaters is listed as a known adverse reaction in the official FDA drug label for BROLUCIZUMAB.
What Other Side Effects Does BROLUCIZUMAB Cause?
Visual impairment (116)
Vision blurred (106)
Eye pain (81)
Vitritis (65)
Ocular hyperaemia (62)
Off label use (62)
Subretinal fluid (62)
Retinal vasculitis (52)
Eye inflammation (50)
Visual acuity reduced (50)
What Other Drugs Cause Vitreous floaters?
AFLIBERCEPT (690)
BROLUCIZUMAB-DBLL (479)
RANIBIZUMAB (458)
BEVACIZUMAB (323)
ADALIMUMAB (300)
DUPILUMAB (300)
CIPROFLOXACIN (189)
FINGOLIMOD (129)
FARICIMAB\FARICIMAB-SVOA (123)
UPADACITINIB (112)
Which BROLUCIZUMAB Alternatives Have Lower Vitreous floaters Risk?
BROLUCIZUMAB vs BROLUCIZUMAB-DBLL
BROLUCIZUMAB vs BROMAZEPAM
BROLUCIZUMAB vs BROMFENAC
BROLUCIZUMAB vs BROMHEXINE
BROLUCIZUMAB vs BROMOCRIPTINE